|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/16/2024 |
$8.39 |
$10.21 |
$8.35 |
$9.64 |
747.70K | 04/17/2024 |
$9.64 |
$11.25 |
$9.64 |
$11.07 |
706.30K | 04/18/2024 |
$11.00 |
$11.00 |
$10.12 |
$10.20 |
401.40K | 04/19/2024 |
$10.20 |
$10.20 |
$9.54 |
$9.68 |
353.70K | 04/22/2024 |
$9.70 |
$10.24 |
$9.29 |
$10.02 |
335.70K |
|
Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines. | |
|
Inovio Pharmaceuticals (INO) has the following price history information. Looking back at INO historical stock prices for the last five trading days, on April 16, 2024, INO opened at $8.39, traded as high as $10.21 and as low as $8.35, and closed at $9.64. Trading volume was a total of 747.70K shares. On April 17, 2024, INO opened at $9.64, traded as high as $11.25 and as low as $9.64, and closed at $11.07. Trading volume was a total of 706.30K shares. On April 18, 2024, INO opened at $11.00, traded as high as $11.00 and as low as $10.12, and closed at $10.20. Trading volume was a total of 401.40K shares. On April 19, 2024, INO opened at $10.20, traded as high as $10.20 and as low as $9.54, and closed at $9.68. Trading volume was a total of 353.70K shares. On April 22, 2024, INO opened at $9.70, traded as high as $10.24 and as low as $9.29, and closed at $10.02. Trading volume was a total of 335.70K shares.
INO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Inovio Pharmaceuticals shares, starting with a $10,000 purchase of INO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$124.80 |
|
End price/share: |
$10.02 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.97% |
|
Average Annual Total Return: |
-22.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$802.54 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/16/2024 | $9.64 | 04/17/2024 | $11.07 | 04/18/2024 | $10.20 | 04/19/2024 | $9.68 | 04/22/2024 | $10.02 |
|
|